A. Younes Et Al. , "An Open-Label Phase II Study of Buparlisib (BKM120) in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL) and Follicular Lymphoma (FL)," 57th Annual Meeting of the American-Society-of-Hematology , vol.126, Florida, United States Of America, 2015
Younes, A. Et Al. 2015. An Open-Label Phase II Study of Buparlisib (BKM120) in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL) and Follicular Lymphoma (FL). 57th Annual Meeting of the American-Society-of-Hematology , (Florida, United States Of America).
Younes, A., Salles, G., Martinelli, G., Bociek, R. G., Barrigon, D. C., Gonzalez Barca, E., ... Turgut, M.(2015). An Open-Label Phase II Study of Buparlisib (BKM120) in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL) and Follicular Lymphoma (FL) . 57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America
Younes, Anas Et Al. "An Open-Label Phase II Study of Buparlisib (BKM120) in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL) and Follicular Lymphoma (FL)," 57th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 2015
Younes, Anas Et Al. "An Open-Label Phase II Study of Buparlisib (BKM120) in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL) and Follicular Lymphoma (FL)." 57th Annual Meeting of the American-Society-of-Hematology , Florida, United States Of America, 2015
Younes, A. Et Al. (2015) . "An Open-Label Phase II Study of Buparlisib (BKM120) in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL) and Follicular Lymphoma (FL)." 57th Annual Meeting of the American-Society-of-Hematology , Florida, United States Of America.
@conferencepaper{conferencepaper, author={Anas Younes Et Al. }, title={An Open-Label Phase II Study of Buparlisib (BKM120) in Patients with Relapsed and Refractory Diffuse Large B-Cell Lymphoma (DLBCL), Mantle Cell Lymphoma (MCL) and Follicular Lymphoma (FL)}, congress name={57th Annual Meeting of the American-Society-of-Hematology}, city={Florida}, country={United States Of America}, year={2015}}